Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
収録刊行物
-
- The Lancet Rheumatology
-
The Lancet Rheumatology 5 (4), e215-e224, 2023-04
Elsevier BV